Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,224 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $503.74 | 14 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $329.89 | 11 | $0 (2020) |
| Horizon Pharma plc | $157.69 | 3 | $0 (2018) |
| Allergan Inc. | $90.83 | 4 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $38.66 | 2 | $0 (2017) |
| Advanced Respiratory, Inc | $26.84 | 1 | $0 (2017) |
| AbbVie Inc. | $25.46 | 1 | $0 (2023) |
| Metacel Pharmaceuticals LLC | $20.68 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $15.30 | 1 | $0 (2017) |
| Indivior Inc. | $14.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.52 | 1 | Merz Pharmaceuticals, LLC ($30.52) |
| 2023 | $201.02 | 6 | Merz Pharmaceuticals, LLC ($154.88) |
| 2022 | $194.79 | 5 | Merz Pharmaceuticals, LLC ($194.79) |
| 2021 | $123.55 | 4 | Merz Pharmaceuticals, LLC ($123.55) |
| 2020 | $91.60 | 3 | MERZ NORTH AMERICA, INC. ($91.60) |
| 2019 | $99.98 | 3 | Merz North America, Inc. ($99.98) |
| 2018 | $280.82 | 7 | Horizon Pharma plc ($140.08) |
| 2017 | $201.46 | 10 | Allergan Inc. ($72.14) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $30.13 | General |
| Category: MUSCULOSKELETAL | ||||||
| 03/28/2018 | Horizon Pharma plc | PRIMARY CARE - DISEASE STATE (Drug) | Food and Beverage | Cash or cash equivalent | $120.77 | General |
| Category: NONE | ||||||
| 02/09/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/06/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $20.67 | General |
| Category: MUSCULOSKELETAL | ||||||
| 12/19/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/03/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: ANTI-MIGRAINE | ||||||
| 09/21/2017 | Allergan Inc. | BOTOX CHRONIC MIGRAINE (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ANTI-MIGRAINE | ||||||
| 08/03/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Musculoskeletal | ||||||
| 06/22/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: OUD | ||||||
| 06/05/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Opioid Induced Constipation | ||||||
| 03/14/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/21/2017 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Airway Clearance Device | ||||||
| 01/30/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/24/2017 | Horizon Pharma plc | NO_PRODUCT (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 502 | 631 | $149,899 | $83,934 |
| 2022 | 4 | 428 | 543 | $131,890 | $75,945 |
| 2021 | 6 | 456 | 573 | $135,367 | $80,828 |
| 2020 | 5 | 298 | 390 | $89,933 | $52,446 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 135 | 144 | $64,800 | $36,163 | 55.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 137 | 251 | $43,925 | $22,080 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 113 | 113 | $25,199 | $15,552 | 61.7% |
| 95887 | Needle measurement of electrical activity in trunk or head muscles | Office | 2023 | 95 | 99 | $12,375 | $7,486 | 60.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 24 | $3,600 | $2,652 | 73.7% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 123 | 129 | $58,050 | $33,800 | 58.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 127 | 236 | $41,300 | $21,768 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $23,415 | $14,519 | 62.0% |
| 95887 | Needle measurement of electrical activity in trunk or head muscles | Office | 2022 | 73 | 73 | $9,125 | $5,857 | 64.2% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 120 | 128 | $57,600 | $35,228 | 61.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 127 | 232 | $40,600 | $21,827 | 53.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 101 | 101 | $22,523 | $14,167 | 62.9% |
| 95887 | Needle measurement and recording of electrical activity of head or trunk muscles | Office | 2021 | 79 | 80 | $10,000 | $6,558 | 65.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $3,684 | $2,298 | 62.4% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 12 | 12 | $960.00 | $751.20 | 78.3% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2020 | 76 | 80 | $36,000 | $22,028 | 61.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 81 | 145 | $25,375 | $13,079 | 51.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 71 | 71 | $15,833 | $9,556 | 60.4% |
| 95887 | Needle measurement and recording of electrical activity of head or trunk muscles | Office | 2020 | 54 | 55 | $6,875 | $4,336 | 63.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 39 | $5,850 | $3,447 | 58.9% |
About Dr. Fred Batkin, M.D
Dr. Fred Batkin, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043240443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fred Batkin, M.D has received a total of $1,224 in payments from pharmaceutical and medical device companies, with $30.52 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,224).
As a Medicare-enrolled provider, Batkin has provided services to 1,684 Medicare beneficiaries, totaling 2,137 services with total Medicare billing of $293,153. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Long Beach, CA
- Active Since 07/03/2006
- Last Updated 10/30/2013
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1043240443
Products in Payments
- Xeomin (Biological) $520.00
- XEOMIN (Biological) $313.63
- PRIMARY CARE - DISEASE STATE (Drug) $120.77
- BOTOX CHRONIC MIGRAINE (Drug) $47.82
- BOTOX THERAPEUTIC (Biological) $43.01
- NUEDEXTA (Drug) $38.66
- The Vest System Model 105 Home Care (Device) $26.84
- BOTOX (Biological) $25.46
- Ozobax (Drug) $20.68
- PENNSAID (Drug) $19.31
- NO_PRODUCT (Drug) $17.61
- Movantik (Drug) $15.30
- SUBOXONE SUBLINGUAL FILM (Drug) $14.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Long Beach
Dr. Jason Koh, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $4,125
Kimberly Bedell, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,902
Nathaniel Dusto, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,987
Dr. Edward Barawid, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,739
Dr. Ronald Takemoto, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,457
Diemha Hoang, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,336